Advertisement

Topics

Landos doses first subject cohort in Phase l trial of BT-11 for IBD

19:00 EDT 12 Jul 2018 | Net Resources International

Landos Biopharma has dosed the first cohort of subjects in a Phase l clinical study designed to investigate the safety...
Read More...

The post Landos doses first subject cohort in Phase l trial of BT-11 for IBD appeared first on Drug Development Technology.

Original Article: Landos doses first subject cohort in Phase l trial of BT-11 for IBD

NEXT ARTICLE

More From BioPortfolio on "Landos doses first subject cohort in Phase l trial of BT-11 for IBD"

Advertisement
Quick Search
Advertisement
Advertisement